机构:[1]Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, China[2]Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine,Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China[3]Department of Otorhinolaryngology, First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, China[4]Department of Head and Neck Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China
CSCO-JunShi Cancer Immunotherapy
Clinical Research Fund, Grant/Award
Number: Y-JS2019-002; Guangdong
Province Science and Technology
Development Special Funds (Frontier and
Key Technology Innovation Direction -
Major Science and Technology Project),
Grant/Award Number: 2017B020226004;
National Natural Science Foundation of China, Grant/Award Numbers: 81772895,
81874134, 81702676; Program of Sun Yat-
Sen University for Clinical Research 5010
Program, Grant/Award Numbers: 201310,
2018015, 2018029
第一作者机构:[1]Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, China[2]Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine,Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China
共同第一作者:
通讯作者:
通讯机构:[1]Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, China[2]Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine,Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China[4]Department of Head and Neck Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China[*1]Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China[*2]Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, 651 Dongfeng East Road, Guangzhou, Guangdong 510060, China
推荐引用方式(GB/T 7714):
Liu You-Ping,Wang Shun-Lan,Zou Xiong,et al.Transcervical endoscopic retropharyngeal lymph node (RPLN) dissection in nasopharyngeal carcinoma with RPLN recurrence.[J].HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK.2021,43(1):98-107.doi:10.1002/hed.26459.
APA:
Liu You-Ping,Wang Shun-Lan,Zou Xiong,You Rui,Yang Qi...&Chen Ming-Yuan.(2021).Transcervical endoscopic retropharyngeal lymph node (RPLN) dissection in nasopharyngeal carcinoma with RPLN recurrence..HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK,43,(1)
MLA:
Liu You-Ping,et al."Transcervical endoscopic retropharyngeal lymph node (RPLN) dissection in nasopharyngeal carcinoma with RPLN recurrence.".HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK 43..1(2021):98-107